[ad_1]
Following AstraZeneca’s statement (22 January) that it would not be able to meet its delivery schedule agreed with the EU for its COVID-19 vaccine, Health Commissioner Stella Kyriakides said that the European Union has pre-financed the development of the vaccine and the production and wants to see the return. She said the new schedule is not acceptable to the European Union.
It is anticipated that the European Medicines Agency (EMA) will grant approval to the AstraZeneca vaccine by the end of the week, currently scheduled for a meeting on 29 January. Though there are some questions of the vaccine’s efficacy with those over 50, it is logistically less challenging than the other vaccines as it does not require storage at very low temperatures.
AstraZeneca informed the Commission last Friday (22 January) that it intends to supply considerably fewer doses than planned in the coming weeks than agreed and announced.
The European Union has pre-financed the development of the vaccine. The European Union wants to know exactly which doses have been produced by AstraZeneca and where exactly so far and if, or to whom, they have been delivered.
The EU wants to know exactly which doses have been produced where by @AstraZeneca so far, and if, or to whom, they have been delivered.
The answers of the company during the Steering Board discussion have not been satisfactory so far. A second meeting is scheduled for tonight.
— Stella Kyriakides (@SKyriakidesEU) January 25, 2021
The joint steering board of the Commission and the 27 member states discussed this with AstraZeneca today. Kyriakides said that the answers of the company have not been satisfactory so far, and that a second meeting is scheduled for tonight (25 January).
The Commission has today proposed to the 27 Mmember states in the Steering Board that an export transparency mechanism will be put in place as soon as possible.
The European Union has supported the rapid development and production of several vaccines against COVID-19 with a total of €2.7 billion. In future, all companies producing vaccines against COVID-19 in the EU will have to provide early notification whenever they want to export vaccines to third countries. The commissioner added that humanitarian deliveries would not be affected by this.
[ad_2]
Source link
